Dose-Escalation Study in Advanced Colon Cancer Patients

NCT00969046 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: EPO906 (patupilone)

Sponsor

Novartis Pharmaceuticals